Demonstrating a ‘practical and business-minded approach’, Norton Rose Fulbright’s full-spectrum IP offering draws on specialists across its six national offices, while it also benefits from access to the firm’s extensive global platform. Toronto-based Jung-Kay Chiu chairs the Canadian practice and specializes in IP acquisition, protection and commercialization, with a focus on the life sciences sphere. In Calgary, Elizabeth Williams is recommended for IP portfolio management and transactional matters; she recently worked alongside the corporate department to advise Canadian Tire on its acquisition of Hudson’s Bay Company’s IP portfolio. Toronto-based David Ng is also noted for IP strategy and prosecution. On the contentious side, the group fields Montreal-based patent litigator Brian Daley; Toronto-based Kristin Wall, whose practice spans litigation and regulatory issues; Vancouver group chair Christopher Wilson; and Toronto’s Daniel Daniele, who has an emphasis on pharmaceutical patent litigation.
Legal 500 Editorial commentary

Accolades

Client satisfaction

Testimonials

Collated independently by Legal 500 research team.

  • ‘NRF has provided us with a wide range of support - everything from patent applications, through to complex IP licensing agreements, which have included international complexities such export control considerations.’

  • ‘It has developed a strong understanding of our business, and the constraints we operate under along with our goals. This adds significant value to its engagements with our teams. It is able to bring in experts when required. Administrative support (deal rooms, etc) run smoothly and collaboratively.’
  • ‘Jeffrey Kang and David Ng essentially form part of our team. Highly trusted advisors who knows our business. Highly responsive and provide good quality work.’

  • ‘The NRF team has the capability to provide service to large and smaller sized clients. It also has very relevant experience in our industry.’

  • ‘Technical knowledge is strong which leads to well-formed patent applications that generate valuable claims. The team is straightforward with its recommendations and doesn't push needless extensions and continuations just to generate business.’

  • ‘Brian Chau does an excellent job in all aspects of IP. We have complete confidence that he will handle our IP matters with professionalism and will provide great value in building our portfolio. John Varriano is an up-and-coming associate who has demonstrated growth and shows good attention to detail.’

Key clients

  • BC Green Pharmaceuticals
  • Canadian Tire
  • De Havilland Aircraft of Canada (formerly Viking Air)
  • Dejero Labs
  • Ferring Pharmaceuticals
  • Graco
  • GSK
  • HSBC
  • Innomar
  • Innovative Medicines Canada
  • Interac
  • Johnson & Johnson

Work highlights

Advised Canadian Tire on its acquisition of the Hudson’s Bay Company’s intellectual property portfolio.
Advised Royal Bank of Canada on its AI patent portfolio, including on its AI/machine learning/blockchain applications.
Advised NOVA Chemicals on its IP commercial work, including drafting and negotiating IP licensing agreements.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Next Generation Partners

Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

Jung-Kay Chiu

Other key lawyers

Elizabeth Williams; David Ng; Brian Daley; Kristin Wall; Christopher Wilson; Daniel Daniele; Jeffrey Kang; John Varriano